ReviewFrontiers in molecular biosciences2023

Inhibitors of riboflavin biosynthetic pathway enzymes as potential antibacterial drugs.

Zeyaul Islam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.